Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Invested Capital: 2022-2024

  • Revolution Medicines' Return on Invested Capital rose 1.00% to -0.36% in Q4 2024 from the same period last year, while for Dec 2024 it was -0.36%, marking a year-over-year increase of 1.00%. This contributed to the annual value of -0.34% for FY2024, which is 5.00% up from last year.
  • Revolution Medicines' Return on Invested Capital amounted to -0.36% in Q4 2024, which was up 1.45% from -0.36% recorded in Q4 2023.
  • Revolution Medicines' 5-year Return on Invested Capital high stood at -0.36% for Q4 2024, and its period low was -0.42% during Q3 2022.
  • Over the past 3 years, Revolution Medicines' median Return on Invested Capital value was -0.38% (recorded in 2022), while the average stood at -0.39%.
  • Data for Revolution Medicines' Return on Invested Capital shows a peak YoY climbed of 2bps (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Revolution Medicines' Return on Invested Capital stood at -0.38% in 2022, then grew by 2bps to -0.36% in 2023, then grew by 1bps to -0.36% in 2024.
  • Its Return on Invested Capital was -0.36% in Q4 2024, compared to -0.36% in Q4 2023 and -0.41% in Q3 2023.